A set of studies focusing on changes in monocyte subset levels report either an expansion of classical (23) and CD14++ CD16+ bona-fide intermediate monocytes (26) or of both intermediate and nonclassical cells (28) or a sole increase in nonclassical monocytes (27) in MS patients. The gene discussed is CD14; the disease is myeloid sarcoma.